Overview
MyPattern is a women's health intelligence platform that compiles data from labs, wearables, medical history, and self-reported symptoms into a single, user-owned timeline to help women understand their bodies. It uses AI to connect symptoms with cycle phase, lab trends, and health history, and presents clear explanations plus a shareable one-page summary for appointments. Unlike some health tools, it does not diagnose or function as a medical device, and it focuses on empowering patients with plain-language context to advocate for better care. Its goal is to give women a centralized, intelligent view of their health data so they can ask informed questions and partner with clinicians to improve outcomes across menstrual health, fertility, menopause, postpartum, and chronic conditions.
Work here?Claim your company
Simplify's take
What believers are saying
- Julie Frahm said over 3,000 women joined the waitlist within months of the May beta.
- Apple listed MyPattern Health on September 25, 2026, signaling real product distribution.
- The July 2026 Washington Business Journal feature gave MyPattern early category visibility and consumer credibility.
What critics are saying
- MyPattern has no defensible clinical moat if Apple, Oura, or Epic copy this workflow.
- The app can cross into medical-device scrutiny once recommendations drive lab ordering and supplement guidance.
- A privacy breach would destroy trust instantly, because users upload highly sensitive reproductive and medical records.
What makes MyPattern unique
- MyPattern launched in 2026 as Red Cell Partners' pre-seed women’s health intelligence platform.
- It links Epic, Cerner, Apple Watch, Oura, Whoop, and Fitbit data into one timeline.
- Julie Frahm’s lived experience anchors a product built around longitudinal pattern recognition, not snapshots.
Help us improve and share your feedback! Did you find this helpful?